Merlin director granted 37,500 RSUs

Montelongo Michael reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Montelongo Michael reported acquisition or exercise transactions in this Form 4 filing.

Merlin, Inc. director Michael Montelongo reported receiving an equity award of 37,500 shares of common stock in the form of restricted stock units. The award consists of 20,000 RSUs that vest in four equal installments every six months starting on September 16, 2026, and 17,500 RSUs that vest in full on the earlier of March 16, 2027 or one day before the company’s 2027 annual shareholder meeting. Each RSU represents a contingent right to receive one share of common stock, and the RSUs do not expire.

Insider Trade Summary

Grant/Award: 37,500 shares

Grant/Award 1 txn

Insider Montelongo Michael

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock	37,500	$0.00	$0.00

Holdings After Transaction: Common stock — 37,500 shares (Direct)

Footnotes (1)

1. F1. Represents an award of (i) 20,000 restricted stock units (RSUs), which vest in four equal installments every six months beginning on September 16, 2026, and (ii) 17,500 RSUs, which vest in full on the earlier to occur of (i) March 16, 2027, and (ii) one day prior to the date of the Issuers 2027 annual meeting of shareholders. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs do not expire.

Key Figures

RSUs granted: 37,500 shares Grant price: $0.00 per share Holdings after grant: 37,500 shares +2 more

5 metrics

RSUs granted 37,500 shares Total restricted stock units awarded to director

Grant price $0.00 per share Reported transaction price for RSU award

Holdings after grant 37,500 shares Total shares reported following this transaction

Tranche 1 RSUs 20,000 RSUs Vesting in four equal installments every six months from Sept. 16, 2026

Single-vest RSUs 17,500 RSUs Vest on March 16, 2027 or one day before 2027 annual meeting

Key Terms

restricted stock units (RSUs), contingent right, annual meeting of shareholders

3 terms

restricted stock units (RSUs) financial

"Represents an award of (i) 20,000 restricted stock units (RSUs), which vest in four equal installments..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

contingent right financial

"Each RSU represents a contingent right to receive one share of Common Stock."

annual meeting of shareholders financial

"vest in full on the earlier to occur of (i) March 16, 2027, and (ii) one day prior to the date of the Issuers 2027 annual meeting of shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Merlin, Inc. (MRLN) report for Michael Montelongo?

Merlin, Inc. reported that director Michael Montelongo received an equity award of 37,500 restricted stock units. These RSUs are compensation, not an open-market purchase, and each unit represents a contingent right to receive one share of Merlin common stock.

How many Merlin (MRLN) shares did Michael Montelongo effectively acquire?

Michael Montelongo was granted 37,500 restricted stock units tied to Merlin common stock. Following the award, his reported direct holdings from this grant total 37,500 shares, subject to the time-based vesting schedule described in the filing’s footnote.

What is the vesting schedule for Michael Montelongo’s Merlin (MRLN) RSU grant?

The grant includes 20,000 RSUs vesting in four equal installments every six months beginning on September 16, 2026. An additional 17,500 RSUs vest in full on March 16, 2027, or one day before Merlin’s 2027 annual shareholder meeting, whichever occurs first.

Did Michael Montelongo pay a purchase price for his Merlin (MRLN) RSU award?

No cash price was paid for this award; the RSUs were granted at a reported price of $0.00 per share. This indicates a compensation-related equity grant rather than an open-market purchase of Merlin common stock.

Do Michael Montelongo’s Merlin (MRLN) RSUs have an expiration date?

According to the filing footnote, the restricted stock units granted to Michael Montelongo do not expire. Instead, they are governed by the vesting schedule, after which each vested RSU converts into one share of Merlin common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 07:28 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Montelongo Michael

(Last) (First) (Middle)

100 CAUSEWAY STREET

23RD FLOOR

(Street)

BOSTON MASSACHUSETTS 02114

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Merlin, Inc. [ MRLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	05/20/2026		A		37,500	A	(1)	37,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of (i) 20,000 restricted stock units (RSUs), which vest in four equal installments every six months beginning on September 16, 2026, and (ii) 17,500 RSUs, which vest in full on the earlier to occur of (i) March 16, 2027, and (ii) one day prior to the date of the Issuers 2027 annual meeting of shareholders. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs do not expire.

Remarks:

	/s/ Leslie Renee Ravestein	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)